Additionally, P210 fragments and P210-specific antibodies have been detected in plaques and circulation of patients with atherosclerotic cardiovascular disease (ASCVD), suggesting the involvement of P210 in human atherosclerotic disease (9, 10). This evidence concerns the gene EVPL and atherosclerosis.